Tribune Therapeutics
ID: 17832309Tribune Therapeutics is a developer of therapeutics for fibrotic diseases founded in 2020 by Georg Vo Beiske, Ole Joergen and Havard Attramadal.
1
Funding Rounds
$40.0m
Money raised
Recent Funding Rounds
Overview
Tribune Therapeutics is a developer of therapeutics for fibrotic diseases founded in 2020 by Georg Vo Beiske, Ole Joergen and Havard Attramadal.
- Website:
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ge*** Vo Be**** |
|
- | |
| Ol* Jo***** |
|
- | |
| Ha**** At******** | - | - | - |
Funding series
Funding Series Analysis
The company Tribune Therapeutics has raised a total of $40m in funding over 1 rounds.
Key Insights:
- Tribune Therapeutics Series A Round, March 2025: $40m
Industries
Tribune Therapeutics is active in the following industries: